Caenorhabditis elegans as a model system to study intercompartmental proteostasis: Interrelation of mitochondrial function, longevity, and neurodegenerative diseases

Developmental Dynamics

Volumn 239, Issue 5, 2010, Pages 1529-1538

  Kirstein Miles, Janine ^a   Morimoto, Richard I ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Aging; C. elegans; mtUPR; Neurodegenerative diseases; Proteostasis

Indexed keywords

MITOCHONDRIAL PROTEIN; PROTEIN MTUPR; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

AGING; APOPTOSIS; CAENORHABDITIS ELEGANS; CELL METABOLISM; CYTOSOL; DEGENERATIVE DISEASE; FRIEDREICH ATAXIA; LIFESPAN; LONGEVITY; MITOCHONDRIAL MEMBRANE; PARKINSON DISEASE; PRIORITY JOURNAL; PROKARYOTE; QUALITY CONTROL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CAENORHABDITIS ELEGANS; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; PROTEIN FOLDING;

CAENORHABDITIS ELEGANS; EUKARYOTA; PROKARYOTA;

EID: 77951554481     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.22292     Document Type: Review

References (79)

1. Apel K, Hirt H. 2004. Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annu Rev Plant Biol 55:373-399. (Pubitemid 38940937)
2. Artal-Sanz M, Tavernarakis N. 2009. Prohibitin couples diapause signalling to mitochondrial metabolism during ageing in C. elegans. Nature 461:793-797.
3. Ben-Zvi A, Miller EA, Morimoto RI. 2009. Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc Natl Acad Sci USA 106:14914-14919.
4. Benedetti C, Haynes CM, Yang Y, Harding HP, Ron D. 2006. Ubiquitin-like protein 5 positively regulates chaperone gene expression in the mitochondrial unfolded protein response. Genetics 174:229-239. (Pubitemid 44427668)
5. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3: 1301-1306.
6. Brignull HR, Moore FE, Tang SJ, Morimoto RI. 2006a. Polyglutamine proteins at the pathogenic threshold display neuron-specific aggregation in a panneuronal Caenorhabditis elegans model. J Neurosci 26:7597-7606.
7. Brignull HR, Morley JF, Garcia SM, Morimoto RI. 2006b. Modeling polyglutamine pathogenesis in C. elegans. Methods Enzymol 412:256-282.
8. Casari G, De Fusco M, Ciarmatori S, Zeviani M, Mora M, Fernandez P, De Michele G, Filla A, Cocozza S, Marconi R, Durr A, Fontaine B, Ballabio A. 1998. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93:973-983. (Pubitemid 28280791)
9. Condo I, Ventura N, Malisan F, Tomassini B, Testi R. 2006. A pool of extramitochondrial frataxin that promotes cell survival. J Biol Chem 281:16750-16756. (Pubitemid 43909630)
10. Curran SP, Leverich EP, Koehler CM, Larsen PL. 2004. Defective mitochondrial protein translocation precludes normal Caenorhabditis elegans development. J Biol Chem 279:54655-54662.
11. Dodson MW, Guo M. 2007. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease. Curr Opin Neurobiol 17:331-337. (Pubitemid 46880329)
12. Fink JK. 2003a. Advances in the hereditary spastic paraplegias. Exp Neurol 184(Suppl 1):S106-110.
13. Fink JK. 2003b. The hereditary spastic paraplegias: nine genes and counting. Arch Neurol 60:1045-1049. (Pubitemid 36975789)
14. Finkel T, Holbrook NJ. 2000. Oxidants, oxidative stress and the biology of ageing. Nature 408:239-247.
15. Fornai F, Schluter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M, Lazzeri G, Busceti CL, Pontarelli F, Battaglia G, Pellegrini A, Nicoletti F, Ruggieri S, Paparelli A, Sudhof TC. 2005. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci U S A 102:3413-3418. (Pubitemid 40328059)
16. Gidalevitz T, Ben-Zvi A, Ho KH, Brignull HR, Morimoto RI. 2006. Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 311:1471-1474. (Pubitemid 43376703)
17. Gidalevitz T, Krupinski T, Garcia S, Morimoto RI. 2009. Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity. PLoS Genet 5:e1000399.
18. Greaves LC, Turnbull DM. 2009. Mitochondrial DNA mutations and ageing. Biochim Biophys Acta 1790:1015-1020.
19. Hamamichi S, Rivas RN, Knight AL, Cao S, Caldwell KA, Caldwell GA. 2008. Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model. Proc Natl Acad Sci USA 105:728-733. (Pubitemid 351171776)
20. Hansen JJ, Durr A, Cournu-Rebeix I, Georgopoulos C, Ang D, Nielsen MN, Davoine CS, Brice A, Fontaine B, Gregersen N, Bross P. 2002. Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am J Hum Genet 70:1328-1332. (Pubitemid 34450582)
21. Hartl FU, Neupert W. 1990. Protein sorting to mitochondria: evolutionary conservations of folding and assembly. Science 247:930-938. (Pubitemid 20081653)
22. Haynes CM, Petrova K, Benedetti C, Yang Y, Ron D. 2007. ClpP mediates activation of a mitochondrial unfolded protein response in C. elegans. Dev Cell 13:467-480. (Pubitemid 47500805)
23. Haynes CM, Yang Y, Blais SP, Neubert TA, Ron D. 2010. The matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7 in C. elegans. Mol Cell 37: 529-540.
24. Heschl MF, Baillie DL. 1989. Characterization of the hsp70 multigene family of Caenorhabditis elegans. DNA 8:233-243.
25. Hoffmann M, Bellance N, Rossignol R, Koopman WJ, Willems PH, Mayatepek E, Bossinger O, Distelmaier F. 2009. C. elegans ATAD-3 is essential for mitochondrial activity and development. PLoS One 4:e7644.
26. Hsu AL, Murphy CT, Kenyon C. 2003. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 300:1142-1145. (Pubitemid 36583098)
27. Jenkins BG, Koroshetz WJ, Beal MF, Rosen BR. 1993. Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy. Neurology 43:2689-2695.
28. Johnson DT, Harris RA, Blair PV, Balaban RS. 2007a. Functional consequences of mitochondrial proteome heterogeneity. Am J Physiol Cell Physiol 292:C698-707.
29. Johnson DT, Harris RA, French S, Blair PV, You J, Bemis KG, Wang M, Balaban RS. 2007b. Tissue heterogeneity of the mammalian mitochondrial proteome. Am J Physiol Cell Physiol 292:C689-697. (Pubitemid 46263468)
30. Kaufman RJ. 1999. Molecular chaperones and the heat shock response. Sponsored by Cold Spring Harbor Laboratory, 6-10 May 1998. Biochim Biophys Acta 1423:R13-27.
31. Kimura K, Tanaka N, Nakamura N, Takano S, Ohkuma S. 2007. Knockdown of mitochondrial heat shock protein 70 promotes progeria-like phenotypes in Caenorhabditis elegans. J Biol Chem 282:5910-5918. (Pubitemid 47093797)
32. Kirstein J, Moliere N, Dougan DA, Turgay K. 2009. Adapting the machine: adaptor proteins for Hsp100/Clp and AAA+ proteases. Nat Rev Microbiol 7: 589-599.
33. Kuwahara T, Koyama A, Koyama S, Yoshina S, Ren CH, Kato T, Mitani S, Iwatsubo T. 2008. A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alphasynuclein transgenic C. elegans. Hum Mol Genet 17:2997-3009.
34. Kuzmin EV, Karpova OV, Elthon TE, Newton KJ. 2004. Mitochondrial respiratory deficiencies signal up-regulation of genes for heat shock proteins. J Biol Chem 279:20672-20677.
35. Lemire BD, Behrendt M, DeCorby A, Gaskova D. 2009. C. elegans longevity pathways converge to decrease mitochondrial membrane potential. Mech Ageing Dev 130:461-465.
36. Lettre G, Hengartner MO. 2006. Developmental apoptosis in C. elegans: a complex CEDnario. Nat Rev Mol Cell Biol 7:97-108. (Pubitemid 43278293)
37. Levine RL, Stadtman ER. 2001. Oxidative modification of proteins during aging. Exp Gerontol 36:1495-1502.
38. Li J, Cai T, Wu P, Cui Z, Chen X, Hou J, Xie Z, Xue P, Shi L, Liu P, Yates JR, 3rd, Yang F. 2009. Proteomic analysis of mitochondria from Caenorhabditis elegans. Proteomics 9:4539-4553.
39. Mann VM, Cooper JM, Javoy-Agid F, Agid Y, Jenner P, Schapira AH. 1990. Mitochondrial function and parental sex effect in Huntington's disease. Lancet 336:749. (Pubitemid 20309171)
40. Martin J, Mahlke K, Pfanner N. 1991. Role of an energized inner membrane in mitochondrial protein import. Delta psi drives the movement of presequences. J Biol Chem 266:18051-18057. (Pubitemid 21908046)
41. Martin LJ, Pan Y, Price AC, Sterling W, Copeland NG, Jenkins NA, Price DL, Lee MK. 2006. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci 26:41-50. (Pubitemid 43089519)
42. Metzstein MM, Stanfield GM, Horvitz HR. 1998. Genetics of programmed cell death in C. elegans: past, present and future. Trends Genet 14:410-416. (Pubitemid 28505585)
43. Morley JF, Brignull HR, Weyers JJ, Morimoto RI. 2002. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci USA 99:10417-10422.
44. Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, Ahringer J, Li H, Kenyon C. 2003. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424:277-283. (Pubitemid 36899363)
45. Narendra D, Tanaka A, Suen DF, Youle RJ. 2008. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183: 795-803.
46. Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, Cookson MR, Youle RJ. 2010. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8:e1000298.
47. Nollen EA, Garcia SM, van Haaften G, Kim S, Chavez A, Morimoto RI, Plasterk RH. 2004. Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc Natl Acad Sci USA 101:6403-6408. (Pubitemid 38585986)
48. Osman C, Merkwirth C, Langer T. 2009. Prohibitins and the functional compartmentalization of mitochondrial membranes. J Cell Sci 122:3823-3830.
49. Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT. 2002. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat Neurosci 5: 731-736.
50. Pastore A, Tozzi G, Gaeta LM, Bertini E, Serafini V, Di Cesare S, Bonetto V, Casoni F, Carrozzo R, Federici G, Piemonte F. 2003. Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: a potential role in the pathogenesis of the disease. J Biol Chem 278:42588-42595.
51. Raha S, Robinson BH. 2000. Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem Sci 25:502-508.
52. Rea SL, Ventura N, Johnson TE. 2007. Relationship between mitochondrial electron transport chain dysfunction, development, and life extension in Caenorhabditis elegans. PLoS Biol 5:e259.
53. Ron D, Walter P. 2007. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8:519-529.
54. Rotig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, Munnich A, Rustin P. 1997. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet 17:215-217.
55. Rousseau E, Dehay B, Ben-Haiem L, Trottier Y, Morange M, Bertolotti A. 2004. Targeting expression of expanded polyglutamine proteins to the endoplasmic reticulum or mitochondria prevents their aggregation. Proc Natl Acad Sci USA 101:9648-9653.
56. Satyal SH, Schmidt E, Kitagawa K, Sondheimer N, Lindquist S, Kramer JM, Morimoto RI. 2000. Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc Natl Acad Sci USA 97:5750-5755.
57. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. 1989. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1:1269.
58. Schmidt E, Seifert M, Baumeister R. 2007. Caenorhabditis elegans as a model system for Parkinson's disease. Neurodegener Dis 4:199-217.
59. Shi Y. 2008. Apoptosome assembly. Methods Enzymol 442:141-156.
60. Simmer F, Moorman C, van der Linden AM, Kuijk E, van den Berghe PV, Kamath RS, Fraser AG, Ahringer J, Plasterk RH. 2003. Genome-wide RNAi of C. elegans using the hypersensitive rrf-3 strain reveals novel gene functions. PLoS Biol 1:E12.
61. Song DD, Shults CW, Sisk A, Rockenstein E, Masliah E. 2004. Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol 186:158-172.
62. Tan FJ, Fire AZ, Hill RB. 2007. Regulation of apoptosis by C. elegans CED-9 in the absence of the C-terminal transmembrane domain. Cell Death Differ 14:1925-1935.
63. van Ham TJ, Thijssen KL, Breitling R, Hofstra RM, Plasterk RH, Nollen EA. 2008. C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet 4: e1000027.
64. Van Raamsdonk JM, Hekimi S. 2009. Deletion of the mitochondrial superoxide dismutase sod-2 extends lifespan in Caenorhabditis elegans. PLoS Genet 5: e1000361.
65. Ved R, Saha S, Westlund B, Perier C, Burnam L, Sluder A, Hoener M, Rodrigues CM, Alfonso A, Steer C, Liu L, Przedborski S, Wolozin B. 2005. Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans. J Biol Chem 280:42655-42668.
66. Veltri KL, Espiritu M, Singh G. 1990. Distinct genomic copy number in mitochondria of different mammalian organs. J Cell Physiol 143:160-164.
67. Ventura N, Rea S, Henderson ST, Condo I, Johnson TE, Testi R. 2005. Reduced expression of frataxin extends the lifespan of Caenorhabditis elegans. Aging Cell 4:109-112.
68. Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RL, Kim J, May J, Tocilescu MA, Liu W, Ko HS, Magrane J, Moore DJ, Dawson VL, Grailhe R, Dawson TM, Li C, Tieu K, Przedborski S. 2010. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci USA 107:378-383.
69. Voos W. 2009. Mitochondrial protein homeostasis: the cooperative roles of chaperones and proteases. Res Microbiol 160:718-725.
70. Voos W, Rottgers K. 2002. Molecular chaperones as essential mediators of mitochondrial biogenesis. Biochim Biophys Acta 1592:51-62.
71. Voos W, Martin H, Krimmer T, Pfanner N. 1999. Mechanisms of protein translocation into mitochondria. Biochim Biophys Acta 1422:235-254.
72. Wallace DC. 2005. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39:359-407.
73. Wang H, Lim PJ, Karbowski M, Monteiro MJ. 2009. Effects of overexpression of huntingtin proteins on mitochondrial integrity. Hum Mol Genet 18:737-752.
74. Whitworth AJ, Pallanck LJ. 2009. The PINK1/Parkin pathway: a mitochondrial quality control system? J Bioenerg Biomembr 41:499-503.
75. Wolozin B, Saha S,Guillily M, Ferree A, Riley M. 2008. Investigating convergent actions of genes linked to familial Parkinson's disease. Neurodegener Dis 5:182-185.
76. Yan N, Xu Y, Shi Y. 2006. 2:1 Stoichiometry of the CED-4-CED-9 complex and the tetrameric CED-4: insights into the regulation of CED-3 activation. Cell Cycle 5:31-34.
77. Yoneda T, Benedetti C, Urano F, Clark SG, Harding HP, Ron D. 2004. Compartment-specific perturbation of protein handling activates genes encoding mitochondrial chaperones. J Cell Sci 117:4055-4066.
78. Young L, Leonhard K, Tatsuta T, Trowsdale J, Langer T. 2001. Role of the ABC transporter Mdl1 in peptide export from mitochondria. Science 291:2135-2138.
79. Zhao Q, Wang J, Levichkin IV, Stasinopoulos S, Ryan MT, Hoogenraad NJ. 2002. A mitochondrial specific stress response in mammalian cells. EMBO J 21:4411-4419.